About INSUN
Company Overview
INSUN is a trading company registered in the United States and was established on July 22, 2019. The company operates the website tradeinsun.com and presents itself as a provider of online trading services. Despite being relatively new, it has drawn attention due to its offering of the popular MetaTrader 4 (MT4) platform, which is widely used among retail traders.
According to its website, INSUN aims to cater to traders looking for a straightforward trading experience. However, beyond the basic platform information, very little is publicly known about the company's specific products or services. The lack of transparency around its operations raises immediate questions for potential clients.
Regulatory Status
INSUN currently holds no known regulatory licences from any financial authority. This absence of oversight is a significant concern, as regulated brokers are required to adhere to strict standards regarding client fund segregation, reporting, and fair trading practices.
The National Futures Association (NFA), a US self-regulatory organization, has flagged INSUN as a 'Suspicious Clone.' This designation suggests that the entity may be mimicking a legitimate broker to deceive traders. The NFA's warning adds a layer of caution for anyone considering engaging with this broker.
Without regulation, clients have limited recourse in the event of disputes or financial loss. Regulatory protection, such as compensation schemes or dispute resolution services, is not available for unregulated brokers like INSUN.
Trading Platform
INSUN offers the MetaTrader 4 (MT4) platform, which is a widely recognized and respected trading platform in the industry. MT4 provides advanced charting tools, automated trading capabilities through Expert Advisors, and a user-friendly interface. It is compatible with desktop, web, and mobile devices.
While the availability of MT4 is a positive aspect, the lack of information about execution types, leverage, or available instruments leaves many questions unanswered. Traders cannot assess whether the platform is offered in a standard or customized version, nor can they verify the reliability of trade execution.
Furthermore, without regulatory oversight, there is no guarantee that the platform operates fairly. Brokers with a clean reputation typically offer MT4 under strict licensing from MetaQuotes, but the legitimacy of INSUN's MT4 offering cannot be confirmed from available public data.
Risk Assessment
FXCanary has assigned INSUN a Scam Risk Score of 75 out of 100, indicating a severe risk level. This score is primarily driven by the broker's lack of regulation, the NFA's suspicious clone flag, and the general lack of verifiable information about its operations.
Traders considering INSUN should be aware of the elevated risks, including the potential for loss of funds without any legal protection. The absence of regulatory oversight means that the broker is not required to maintain segregated accounts or submit to audits.
Additionally, the 'Suspicious Clone' warning suggests that the broker may be impersonating a legitimate entity. Such clones often engage in fraudulent activities, including denial of withdrawals or manipulation of trading conditions. Extreme caution is advised.
Conclusion
INSUN presents itself as a US-based trading company offering MT4, but it operates entirely without regulatory supervision. The NFA's flagging of the broker as a suspicious clone further undermines its credibility.
For traders, the combination of an unregulated status and a high-risk score makes INSUN a dangerous choice. Without independent verification of its claims or any form of client protection, the prudent course is to avoid this broker entirely.
FXCanary recommends that traders only consider regulated brokers with a proven track record. In the case of INSUN, the risks far outweigh any potential benefits, and the lack of transparency should be a deal-breaker for even experienced traders.
Overview compiled by FXCanary from regulatory records and public data. full INSUN review